ALLOSOURCE® LAUNCHES UROCONNEX™ FASCIA AS PART OF ITS PORTFOLIO OF ALLOGRAFTS FOR USE IN WOMEN’S HEALTH PROCEDURES
CENTENNIAL, Colo., Oct. 5, 2026
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()
ALLOSOURCE® LAUNCHES UROCONNEX™ FASCIA AS PART OF ITS PORTFOLIO OF ALLOGRAFTS FOR USE IN WOMEN’S HEALTH PROCEDURES
PR Newswire
CENTENNIAL, Colo., Oct. 5, 2026
CENTENNIAL, Colo., Oct. 5, 2026 /PRNewswire/ — AlloSource®, a life sciences organization that helps restore patient functionality by transforming the gift of human tissue donation into enhanced medical products, announced the addition of UroConnex™ Fascia to its portfolio of allografts for use in women’s health procedures.

UroConnex is a human fascia allograft offered in a variety of options to meet the diversity of women’s health procedural needs. It comes in both freeze-dried and frozen formats, as well as a wide range of sizes to help provide structural support in the surgical site. It also streamlines urogynecological procedures and reduces patient risk by providing an alternative to using autologous fascia.
“Today marks not just the launch of a product, but a commitment to innovation and a product offering that empowers healthcare professionals and enhances patient care in Women’s Health. Together, we are setting high standards for quality and excellence in every procedure,” said Charles Manuele, AlloSource Senior Director, Soft Tissue Matrices.
UroConnex is a convenient, off-the-shelf fascia tissue, with a natural feel, offering ideal handling characteristics for precision placement. In addition, it is terminally sterilized through irradiation to a SAL of 10-6 to minimize risk of infection.*
In addition to UroConnex Fascia, AlloMend® Duo Acellular Dermal Matrix and AlloWrap® Amniotic Membrane are part of AlloSource’s allograft portfolio that allows surgeons to support repair and reconstruction in critical women’s health conditions such as pelvic organ prolapse, fistula and urinary incontinence.
For more information on AlloSource’s new product UroConnex Fascia and the entire Women’s Health portfolio, please visit allosource/products/urogynecology.
About AlloSource
AlloSource, a life sciences organization, helps restore patient functionality by transforming the gift of human tissue donation into enhanced medical products that enable a life of movement, health, and wellbeing. The organization partners with medical professionals and biomedical companies who share our drive for innovation and quality in the use of human tissue allografts for medical advancements. Headquartered in Centennial, Colorado, AlloSource has served a global marketplace since 1994. Learn more at allosource.org.
*Data on file at AlloSource
Media Contact
Cindy Mason
AlloSource
720. 873. 4744
cmason@allosource.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/allosource-launches-uroconnex-fascia-as-part-of-its-portfolio-of-allografts-for-use-in-womens-health-procedures-302898605.html
SOURCE AlloSource


